Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503277 | 1.00 | TSHR (0.38) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL7636275 | 0.91 | TSHR (0.32) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL5142703 | 0.91 | TSHR (0.32) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL8092800 | 0.87 | — | — | |
| SCHEMBL4659795 | 0.87 | — | — | |
| SCHEMBL15158095 | 0.85 | — | — | |
| SCHEMBL15158094 | 0.85 | — | — | |
| SCHEMBL30032966 | 0.80 | — | — | |
| SCHEMBL5612650 | 0.79 | ALDH1A1 (0.35) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL17938590 | 0.79 | ALDH1A1 (0.35) | TSHRALDH1A1CYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118446-A | Heat-resistant acrylic ester-styrene-acrylonitrile core-shell grafted copolymer, latex thereof and preparation method thereof | 上海中化科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120118447-A | Silicon-containing acrylic ester-styrene-acrylonitrile core-shell graft copolymer, latex thereof and preparation method thereof | 上海中化科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| US-20240248401-A1 | RESIN AND 193 NM DRY PHOTORESIST CONTAINING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | CHINA ADVANCED LITHOGRAPHIC MATERIAL TECHNOLOGY CO., LTD. (CN) | 2024-07-25 | — | — | US | claimed |
| CN-118221941-A | Silicon-containing acrylic ester-styrene-acrylonitrile core-shell grafted copolymer and preparation method thereof | 上海中化科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-11737957-B2 | Dental curable composition including chain transfer agent | SHOFU INC. (JP) | 2023-08-29 | — | — | US | claimed |
| US-20230212340-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Universität Zürich (CH) | 2023-07-06 | — | — | US | claimed |
| EP-4069316-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Universität Zürich (CH) | 2022-10-12 | — | — | EP | claimed |
| WO-2021110991-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Universität Zürich (CH) | 2021-06-10 | — | — | WO | claimed |
| US-20180369076-A1 | DENTAL CURABLE COMPOSITION INCLUDING CHAIN TRANSFER AGENT | SHOFU INC (JP) | 2018-12-27 | — | — | US | claimed |
| EP-2586804-A2 | Photoradically and thermally radically curable composition | KANEKA CORPORATION (JP) | 2013-05-01 | — | — | EP | claimed |
| US-8084558-B2 | Preparation of transition metal nanoparticles and surfaces modified with (co)polymers synthesized by RAFT | UNIVERSITY OF SOUTHERN MISSISSIPPI (US) | 2011-12-27 | — | — | US | claimed |
| EP-2152830-A1 | CORROSION-PREVENTIVE ADHESIVE COMPOSITIONS | Henkel AG & Co. KGaA (DE) | 2010-02-17 | — | — | EP | claimed |
| EP-1149075-B1 | SYNTHESIS OF DITHIOESTER CHAIN TRANSFER AGENTS | COMMW SCIENT IND RES ORG (AU) | 2008-12-31 | — | — | EP | claimed |
| WO-2008147683-A1 | CORROSION-PREVENTIVE ADHESIVE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2008-12-04 | — | — | WO | claimed |
| US-20080292801-A1 | Corrosion-Preventive Adhesive Compositions | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-11-27 | — | — | US | claimed |
| US-6268452-B1 | POLYMERIZATION OF DIALKYLALLYLAMINE WITH POLYMERIZATION OF ADDITION SALT IN SOLVENT AND RADICAL POLYMER POLYMERIZATION WITH AZO COMPOUNDS | NITTO BOSEKI CO., LTD. (JP) | 2001-07-31 | — | — | US | claimed |
| US-4533652-A | Azo polymerization initiator composition | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1985-08-06 | — | — | US | claimed |
| US-4208005-A | Method for mounting parts on circuit boards | HITACHI, LTD. (JP) | 1980-06-17 | — | — | US | claimed |
| US-6391433-B1 | — | — | None | — | — | US | disclosed |
| US-3931111-A | SOLUBLE HYDROPHILIC POLYMERS AND PROCESS FOR PROCESSING THE SAME | CESKOSLOVENSKA AKADAMIE VED (CS) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212340-A1 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | REN, FLT4, FLT1 | TSHR 2285/4885ALDH1A1 1824/4885CYP2D6 3896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.